\-\ Texto\\:\\ \ \(0\)\
\-\ vitals\\ demonstrates\\ hypertension\\ \\(\\>190\\/\\>110\\)\\ without\\ laboratory\\ evidence\\ of\\ end\\-organ\\ damage\\ \\(i\\.e\\.\\,\\ hypertensive\\ urgency\\)\\.\ \(0\)\
\-\ pe\\ is\\ normal\\ with\\ non\\-focal\\ neurologic\\ exam\\.\ \(0\)\
\-\ bun\\ \\-\\ 17\ \(0\)\
\-\ creatinine\\ \\-\\ 1\\.2\ \(0\)\
\-\ the\\ most\\ significant\\ therapy\\ for\\ those\\ with\\ symptomatic\\ adpkd\\ involves\\ the\\ management\\ of\\ hypertension\\ and\\ associated\\ sequelae\\.\\ screening\\ for\\ mca\\ berry\\ aneurysms\\.\ \(0\)\
\-\ multiple\\,\\ bilateral\\,\\ cystic\\ lesions\\ are\\ present\\ on\\ non\\-contrast\\ mr\\.\\ \\ cysts\\ do\\ not\\ enhance\\ with\\ contrast\\ on\\ mr\\.\\ \\ 3d\\ mra\\ demonstrates\\ the\\ distribution\\ of\\ cysts\\.\\ \\ there\\ are\\ no\\ cystic\\ lesions\\ in\\ the\\ surrounding\\ tissues\\ or\\ organs\\.\ \(0\)\
\-\ autosomal\\ dominant\\ \\"adult\\"\\ polycystic\\ kidney\\ disease\\ \\(adpkd\\)\\.\\ \\ \ \(0\)\
\-\ family\\ hx\\ revealed\\ pt\\'s\\ father\\ with\\ history\\ of\\ htn\\,\\ rf\\,\\ and\\ subarachnoid\\ hemmorhage\\.\ \(0\)\
\-\ 1\\.\\ renal\\ cysts\ \(0\)\
\-\ 2\\.\\ acquired\\ polycystic\\ disease\\ \ \(0\)\
\-\ 3\\.\\ autosomal\\ recessive\\ polycystic\\ kidney\\ disease\\ \ \(0\)\
\-\ 4\\.\\ medullary\\ kidney\\ disorders\\ \ \(0\)\
\-\ \\ \\ \\ \\-medullary\\ sponge\\ kidney\ \(1\)\
\-\ \\ \\ \\ \\-medullary\\ cystic\\ kidney\ \(1\)\
\-\ 41\\ y\\/o\\ black\\ male\\ presented\\ to\\ the\\ er\\ with\\ atypical\\ chest\\ pain\\.\ \(0\)\
\-\ with\\ routine\\ screening\\ of\\ blood\\ pressure\\,\\ hypertension\\ has\\ become\\ the\\ leading\\ initial\\ presenting\\ symptom\\ of\\ autosomal\\ dominant\\ polycystic\\ kidney\\ disease\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ polycystic\\:\\ 0\\.34712240444275017\ \(0\)\
\-\ kidney\\:\\ 0\\.3459603938531345\ \(0\)\
\-\ autosomal\\:\\ 0\\.25396926457438057\ \(0\)\
\-\ medullary\\:\\ 0\\.21776087718693932\ \(0\)\
\-\ adpkd\\:\\ 0\\.19928161866597602\ \(0\)\
\-\ hypertension\\:\\ 0\\.18839418356248916\ \(0\)\
\-\ cysts\\:\\ 0\\.18658030935010503\ \(0\)\
\-\ dominant\\:\\ 0\\.15361526623188043\ \(0\)\
\-\ cystic\\:\\ 0\\.1482913334576904\ \(0\)\
\-\ disease\\:\\ 0\\.13780718315541984\ \(0\)\
\-\ screening\\:\\ 0\\.13334417533715676\ \(0\)\
\-\ berry\\:\\ 0\\.1154475896255548\ \(0\)\
\-\ hemmorhage\\:\\ 0\\.10961377732773535\ \(0\)\
\-\ mr\\:\\ 0\\.10621138104379801\ \(0\)\
\-\ urgency\\:\\ 0\\.10226404304388582\ \(0\)\
\-\ sponge\\:\\ 0\\.09964080933298801\ \(0\)\
\-\ the\\:\\ 0\\.0982605535705571\ \(0\)\
\-\ rf\\:\\ 0\\.09812488734695796\ \(0\)\
\-\ 3d\\:\\ 0\\.09675356910543487\ \(0\)\
\-\ with\\:\\ 0\\.09642682122129027\ \(0\)\
\-\ of\\:\\ 0\\.09636924062298156\ \(0\)\
\-\ recessive\\:\\ 0\\.09550165363606014\ \(0\)\
\-\ lesions\\:\\ 0\\.09427218511261627\ \(0\)\
\-\ aneurysms\\:\\ 0\\.08779664324061837\ \(0\)\
\-\ father\\:\\ 0\\.08744992883797793\ \(0\)\
\-\ sequelae\\:\\ 0\\.08711137318319942\ \(0\)\
\-\ 110\\:\\ 0\\.08614103130810838\ \(0\)\
\-\ hypertensive\\:\\ 0\\.08523201633771517\ \(0\)\
\-\ mca\\:\\ 0\\.08494134076528898\ \(0\)\
\-\ organs\\:\\ 0\\.08465642152479351\ \(0\)\
\-\ black\\:\\ 0\\.08410297054305155\ \(0\)\
\-\ creatinine\\:\\ 0\\.0835700225237659\ \(0\)\
\-\ symptom\\:\\ 0\\.0835700225237659\ \(0\)\
\-\ demonstrates\\:\\ 0\\.08246628104407096\ \(0\)\
\-\ htn\\:\\ 0\\.08184632867493798\ \(0\)\
\-\ mra\\:\\ 0\\.08116645646093966\ \(0\)\
\-\ damage\\:\\ 0\\.07989610671425915\ \(0\)\
\-\ contrast\\:\\ 0\\.07975626888215703\ \(0\)\
\-\ bun\\:\\ 0\\.07910752846746952\ \(0\)\
\-\ acquired\\:\\ 0\\.07910752846746952\ \(0\)\
\-\ adult\\:\\ 0\\.07570637820087311\ \(0\)\
\-\ 41\\:\\ 0\\.07525904834296784\ \(0\)\
\-\ hx\\:\\ 0\\.07468345353004618\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.07386106104567391\ \(0\)\
\-\ enhance\\:\\ 0\\.07346684593475586\ \(0\)\
\-\ leading\\:\\ 0\\.0729574847264394\ \(0\)\
\-\ become\\:\\ 0\\.07283291293987619\ \(0\)\
\-\ vitals\\:\\ 0\\.07246554102978342\ \(0\)\
\-\ disorders\\:\\ 0\\.07246554102978342\ \(0\)\
\-\ involves\\:\\ 0\\.07141656194963762\ \(0\)\
\-\ those\\:\\ 0\\.07023036643810515\ \(0\)\
\-\ distribution\\:\\ 0\\.06962233435295455\ \(0\)\
\-\ do\\:\\ 0\\.06802724874785446\ \(0\)\
\-\ pe\\:\\ 0\\.06785070725112372\ \(0\)\
\-\ atypical\\:\\ 0\\.06733371924619666\ \(0\)\
\-\ 17\\:\\ 0\\.06699910064205673\ \(0\)\
\-\ neurologic\\:\\ 0\\.06558274965181815\ \(0\)\
\-\ tissues\\:\\ 0\\.06471048553529885\ \(0\)\
\-\ family\\:\\ 0\\.06457011416366219\ \(0\)\
\-\ presenting\\:\\ 0\\.06429341426156164\ \(0\)\
\-\ routine\\:\\ 0\\.06355883494184734\ \(0\)\
\-\ symptomatic\\:\\ 0\\.06311017649522799\ \(0\)\
\-\ pressure\\:\\ 0\\.062492573035036095\ \(0\)\
\-\ are\\:\\ 0\\.06228678428325879\ \(0\)\
\-\ er\\:\\ 0\\.06138750050579485\ \(0\)\
\-\ management\\:\\ 0\\.060624324194668934\ \(0\)\
\-\ laboratory\\:\\ 0\\.05959983807704802\ \(0\)\
\-\ pt\\:\\ 0\\.05906599111980519\ \(0\)\
\-\ initial\\:\\ 0\\.05505845169714578\ \(0\)\
\-\ surrounding\\:\\ 0\\.05473751754055153\ \(0\)\
\-\ revealed\\:\\ 0\\.053815554060387766\ \(0\)\
\-\ renal\\:\\ 0\\.05110986767989265\ \(0\)\
\-\ for\\:\\ 0\\.04975206586463212\ \(0\)\
\-\ on\\:\\ 0\\.049575580166144835\ \(0\)\
\-\ presented\\:\\ 0\\.04786097228878332\ \(0\)\
\-\ blood\\:\\ 0\\.047665510319357646\ \(0\)\
\-\ significant\\:\\ 0\\.047387783256702\ \(0\)\
\-\ therapy\\:\\ 0\\.04715689943118366\ \(0\)\
\-\ evidence\\:\\ 0\\.04658538792838958\ \(0\)\
\-\ bilateral\\:\\ 0\\.04410965547777706\ \(0\)\
\-\ chest\\:\\ 0\\.043322874433184326\ \(0\)\
\-\ without\\:\\ 0\\.04329100741801121\ \(0\)\
\-\ associated\\:\\ 0\\.0432592108272384\ \(0\)\
\-\ most\\:\\ 0\\.04271385230974257\ \(0\)\
\-\ present\\:\\ 0\\.0421148916741845\ \(0\)\
\-\ exam\\:\\ 0\\.04131614816459264\ \(0\)\
\-\ multiple\\:\\ 0\\.04014423359848644\ \(0\)\
\-\ has\\:\\ 0\\.03748906213536487\ \(0\)\
\-\ male\\:\\ 0\\.03654255114543537\ \(0\)\
\-\ and\\:\\ 0\\.03391922011802452\ \(0\)\
\-\ normal\\:\\ 0\\.03351030889649408\ \(0\)\
\-\ there\\:\\ 0\\.03265703376447711\ \(0\)\
\-\ not\\:\\ 0\\.032400906398856975\ \(0\)\
\-\ history\\:\\ 0\\.031357061455503786\ \(0\)\
\-\ pain\\:\\ 0\\.029369137092021536\ \(0\)\
\-\ or\\:\\ 0\\.02855212152235433\ \(0\)\
\-\ no\\:\\ 0\\.026689566763051144\ \(0\)\
\-\ is\\:\\ 0\\.022476552711333503\ \(0\)\
\-\ to\\:\\ 0\\.02051836635092342\ \(0\)\
\-\ in\\:\\ 0\\.02041737499423917\ \(0\)\
